Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma

Affiliations

• ¹ Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.
• ² Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
• ³ Department of Hematology-Oncology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea.
• ⁴ Department of Hematology-Oncology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
• ⁵ Department of Hematology- Oncology, Inje University Haeundae Paik Hospital, Busan, Korea.
• ⁶ Department of Hematology-Oncology, Dong-A University Hospital, Busan, Korea.
• ⁷ Department of Hematology-Oncology, Daegu Catholic University Hospital, Daegu Catholic University School of Medicine, Daegu, Korea.
• ⁸ Department of Hematology-Oncology, Keimyung University School of Medicine, Daegu, Korea.
• ⁹ Department of Hematology-Oncology, Inje University Busan Paik Hospital, Busan, Korea.
• ¹⁰ Department of Hematology-Oncology, Yeungnam University Hospital, Daegu, Korea.